Announcements Trials
Browse Landscape

Phase

Phase 4 26Phase 3 19Phase NA 17Phase 2 13Phase 1/2 3Phase 1 2Phase 2/3 1

Status

Recruiting 1Completed 1

Sponsor Class

OTHER 1INDUSTRY 1

Study Type

Interventional 2

Sponsor

Cancer Type

Tumor-Agnostic 1

Conditions

Neoplasms 1Infratentorial Neoplasms 1

Interventions

Cyclophosphamide 624pembrolizumab 500Paclitaxel 456Gemcitabine 438Carboplatin 435Cisplatin 418Radiotherapy 380fludarabine 365Nivolumab 340Docetaxel 277Bevacizumab 276Irinotecan 257Magnetic Resonance Spectroscopy 242Fluorouracil 228Dexamethasone 225Specimen Handling 221Capecitabine 218Rituximab 205Cytarabine 201Oxaliplatin 200Ipilimumab 199Temozolomide 197Biopsy 196fludarabine phosphate 194Etoposide 181Lenalidomide 176Doxorubicin 175Leucovorin 173Cetuximab 171Injections 170

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 1 × Interventional × Fentanyl × Clear all
NCT06953453 2025-09-25

A Study of Inhaled Fentanyl Aerosol in Chinese Patients With Malignant Tumors

Lee's Pharmaceutical Limited

Phase 1 Recruiting
100 enrolled
Tumor-Agnostic

Neoplasms

NCT04955236 2022-04-07

Partial Scalp Block in Posterior Fossa Surgery

Kasr El Aini Hospital

Phase 1 Completed
40 enrolled

Infratentorial Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡